London - A weight loss drug made by GlaxoSmithKline, Alli, has just been approved to be sold in Europe. Alli has been sold in the U.S. for over a year now. The drug is for those who are overweight or obese and the European Medicines Agency gave their approval on January 21, 2009. The drug will be available in all 27 member countries that includes Norway in Europe in the next few months when the drug is launched.
The price has not been set yet in Europe but comparing it to the U.S. dollar it would cost about 1 euro a day in Europe if the price is set the same. Although not replace dieting and exercising, the drug is known to be effective in enhancing the dieting process.
Alli has helped those who use it correctly lose an extra 50 percent in weight. When they would normally lose 2 pounds with diet and exercise alone, taking Alli along with the diet and exercise helped them lose an extra pound to make it a total of 3. The pill also helps those who use it to steadily lose weight while they learn a healthier lifestyle and are eating a low calorie, low fat diet.
No Comments, Comment or Ping
Reply to “Non Prescription Weight Loss Pill Gets European Go Ahead”